MyFinsight
Home
Blog
About
Contact
Download
Download image
Short-term marketable
securities
$70,791K
Cash and cash
equivalents
$19,960K
Accounts receivable,
prepaid expenses and...
$5,565K
Total current assets
$96,316K
Marketable securities
$60,612K
Other assets
$2,771K
Property and equipment,
net
$761K
Total assets
$160,460K
Total liabilities and
stockholders' equity
$160,460K
Total stockholders'
equity
$103,082K
Total liabilities
$57,378K
Accumulated deficit
-$967,784K
Additional paidin capital
$1,070,255K
Total current
liabilities
$28,645K
Deferred income, net of
current portion
$16,168K
Contingent consideration
$11,000K
Other liabilities
$1,565K
Accumulated other
comprehensive income
$610K
Common stock, 0.00001
par value...
$1K
Accounts payable
$13,158K
Accrued expenses
$8,791K
Deferred income
$3,943K
Other current
liabilities
$2,753K
Back
Back
Balance Sheet
source: myfinsight.com
Aclaris Therapeutics, Inc. (ACRS)
Aclaris Therapeutics, Inc. (ACRS)